Stockscreener 앱 받기
8.23
0.24%
-0.02
Q 32 Bio Inc 주식(QTTB)의 최신 뉴스
Oppenheimer reiterates Q32 Bio stock rating on durable trial data By Investing.com - Investing.com Nigeria
Why is Q32 Bio stock sliding today? - Investing.com
Why is Q32 Bio stock surging today? - Investing.com
Q32 Bio presents 36-week SIGNAL-AA Part B results; 35.3% mean SALT reduction, durable off-drug responses - TradingView
Q32 Bio Presents Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata in a Late-Breaker at the European Academy of Dermatology and Venereology Congress 2026 - PR Newswire
Q32 Bio: Durable Hair Regrowth Remains The Goal (NASDAQ:QTTB) - Seeking Alpha
Q32 Bio Inc. (QTTB) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Q32 Bio Announces Upcoming Late-Breaking Presentation of Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata at the European Academy of Dermatology and Venereology Congress 2026 - PR Newswire
Q32 Bio Inc.(NasdaqCM: QTTB) added to S&P Global BMI Index - marketscreener.com
Q32 Bio Inc. (QTTB) Shares Fall 2.95% to $10.54, Sitting at Midpoint of Support and ResistanceReversal Setup Alerts - dars.gov.et
Q32 (QTTB) Drifts Near $10.96 as Market Awaits Catalyst 2026-09-17Rectangle Pattern - dars.gov.et
Cantor Fitzgerald reiterates Q32 Bio stock rating on hair loss data - Investing.com
Q32 Bio Appoints José Trevejo as CMO, Ellie Hershberger as CDO - citybiz
Form 8K Q32 Bio Inc For: 14 September By Investing.com - Investing.com Canada
Q32 Bio appoints new CMO and CDO as it advances alopecia areata drug bempikibart to late-stage trials. - Pluang
QTTB: Q32 Bio Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Down 23.1% in 4 Weeks, Here's Why Q32 Bio (QTTB) Looks Ripe for a Turnaround - Yahoo Finance
Q32 Bio Inc. (QTTB) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits
Q32 Bio to present at three major healthcare investor conferences in September 2026 - pluang.com
Q32 Bio to Participate in Upcoming September Investor Conferences - TradingView
Q32 Bio (NASDAQ: FIXX) CFO’s 3,972-share tax sale detailed - Stock Titan
Q32 Bio CFO Lee Kalowski Executes Automatic RSU Tax Withholding Share Sale - Kalkine Media
Q32 Bio CEO Jodie Morrison sells $163,033 in company stock - Investing.com
Q32 Bio CEO Jodie Morrison sells $163,033 in company stock By Investing.com - Investing.com UK
Q32 Bio (FIXX) CEO’s automatic tax sale leaves 343,259 shares - Stock Titan
Q32 Bio: A Deep Dive (NASDAQ:QTTB) - Seeking Alpha
Wall Street Analysts Believe Q32 Bio (QTTB) Could Rally 163.42%: Here's is How to Trade - qz.com
Q32 Bio: The Efficacy Is Modest, The Valuation Is Not (NASDAQ:QTTB) - Seeking Alpha
Q32 Bio Sees Unusually Large Options Volume (NASDAQ:QTTB) - MarketBeat
Q32 (QTTB) Earnings Snapshot: The Bottom-Line Figure Outpaces Its Comparison for the Current Session; Price Move - vinanet.vn
Q32 Bio Company Profile & Introduction - Moomoo
Wall Street Analysts See an 182.18% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High? - Yahoo Finance
Q32 Bio (NASDAQ:QTTB) stock in focus after mid-stage trial data - Kalkine Media
Point72 discloses 4.95% Q32 Bio Inc. (QTTB) holding in Schedule 13G/A - Stock Titan
Q32 Bio Inc. (QTTB) major holders cut reported stake to 0% - Stock Titan
Renaissance Technologies LLC Acquires 107,315 Shares of Q32 Bio Inc. $QTTB - MarketBeat
Q32 Bio (QTTB) Advances 2.34% as Shares Hold Above Key SupportMean Reversion Trade - vinanet.vn
Q32 Bio (QTTB) Holds Near $15.37 as Shares Consolidate Between Key Support and ResistanceMoney Flow - dars.gov.et
Q32 Bio Inc (NASDAQ: QTTB) Stock Price, News & Analysis - Kalkine
Q32 Bio Inc (QTTB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HC Wainwright Forecasts Q32 Bio's Q3 Earnings (NASDAQ:QTTB) - MarketBeat
Q32 Bio Inc. (NASDAQ:QTTB) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Q32 Bio Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Q32 Bio tops estimates as alopecia drug advances toward late-stage trials (QTTB:NASDAQ) - Seeking Alpha
Q32 Bio Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Q32 Bio Inc. posts second quarter 2026 results and updates corporate outlook - Traders Union
Q32 Bio reports Q2 2026 net loss $8.9M, cash $106.3M and $200M July offering - TradingView
Q32 Bio Inc. 2Q 2026: Net loss $(8.95)M, EPS $(0.44) — 10-Q Summary - TradingView
Q32 Bio (Nasdaq: QTTB) adds $187.6M follow-on cash for AA drug - Stock Titan
Q32 Bio (Nasdaq: QTTB) reports AA trial gains and $200M raise - Stock Titan
Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire
Q32 Bio Inc. (QTTB) Earnings, Actual EPS, EPS Estimates & Results - Stocktwits
Q32 Bio Inc. Revenue Breakdown – NASDAQ:QTTB - TradingView
Q32 Bio Inc expected to post a loss of 54 cents a shareEarnings Preview - TradingView
Q32 Bio Inc. (QTTB) investors disclose 5.49% stake in Schedule 13G/A - Stock Titan
Q32 Bio Inc. SEC Filing (Jul 29, 2026) - Stock Titan
H.C. Wainwright raises Q32 Bio stock price target to $36 on alopecia drug outlook - Investing.com
Q32 Bio Inc (QTTB) Balance Sheet - TradingKey
Q32 Bio Inc (QTTB) Income Statement - TradingKey
Q32 Bio Inc (QTTB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Q32 Bio Inc (QTTB) Cash Flow - TradingKey
QTTB|Q32 Bio Inc|Price:15.060|Chg%:-0.150 - TradingKey
QTTB|Q32 Bio Inc|Price:15.140|Chg%:-0.010 - TradingKey
0.05%
0.82%
자본화:
|
볼륨(24시간):